Welcome to the Research Vault
Welcome to the Research Vault — where science meets truth.
This is our central archive for both modern discoveries and legacy research related to natural healing, integrative therapies, and non-toxic approaches to disease. Inside our Research Vault, you’ll find clinical studies, historical documents, and exclusive white papers that challenge conventional thinking and support a more holistic, patient-centered model of care. Whether you’re a clinician, researcher, or truth seeker, the Research Vault is designed to equip you with credible, compelling information that empowers healing without compromise.
We’re honored to offer our community access to the following research white papers.
White Papers
- Laetrile / Vitamin B17 / Amygdalin as a Cancer Prevention & Treatment (an organic compound of the Nitrilosides family of plants).
RNC-Legality, Legitimacy and Clinical Adoption of B17 (Laetrile-Amygdalin)
Amygdalin and the Genome: A Guide to Genes Implicated in Vitamin B17 Research
Amygdalin Research Compilation (2014 – present)
- 2014-08-10 – Advanced research on anti-tumor effects of amygdalin – PubMed
- 2014-10-15 – Amygdalin influences bladder cancer cell adhesion and invasion in vitro – PubMed
- 2016-01-24 – Amygdalin Regulates Apoptosis and Adhesion in Hs578T Triple-Negative Breast Cancer Cells – PMC
- 2016-03 – Amygdalin blocks the in vitro adhesion and invasion of renal cell carcinoma cells by an integrin-dependent mechanism – PubMed
- 2017-04-20 –Antimutagenic, Antirecombinogenic, and Antitumor Effect of Amygdalin in a Yeast Cell-Based Test and Mammalian Cell Lines – PubMed
- 2018-05-03 – Effects of the Gut microbiota on Amygdalin and its use as an anti-cancer therapy_ Substantial review on the key components involved in altering dose efficacy and toxicity – PubMed
- 2018 – Amygdalin from Apricot Kernels Induces Apoptosis and Causes Cell Cycle Arrest in Cancer Cells_ An Updated Review – PubMed
- 2019-03 – Potential toxicity of cyanogenic glycoside amygdalin and bitter apricot seed in rabbits-Health status evaluation – PubMed
- 2019-07-12 – Amygdalin Modulates Prostate Cancer Cell Adhesion and Migration In Vitro – PubMed
- 2020-05-15 – Amygdalin-Therapeutic Effects and Toxicity
- 2020-05-23 – Amygdalin – A pharmacological and toxicological review – PubMed
- 2021-04-26 –Amygdalin_ Toxicity, Anticancer Activity and Analytical Procedures for Its Determination in Plant Seeds – PMC
- 2022-04-20 – Amygdalin potentiates the anti-cancer effect of Sorafenib on Ehrlich ascites carcinoma and ameliorates the associated liver damage
- 2022-06-04 – Amygdalin Exerts Antitumor Activity in Taxane-Resistant Prostate Cancer Cells
- 2022-10-12 – Amygdalin_ A Review on Its Characteristics, Antioxidant Potential, Gastrointestinal Microbiota Intervention, Anticancer Therapeutic and Mechanisms, Toxicity, and Encapsulation – PMC
- 2023-03-04 – Onco-immunity and therapeutic application of amygdalin_ A review – PubMed
- 2023-09-19 – Amygdalin as a Promising Anticancer Agent-Molecular Mechanisms and Future Perspectives
- 2024-04 – Docking and Molecular Dynamics Simulation Revealed the Potential Inhibitory Activity of Amygdalin in Triple-Negative Breast Cancer Therapeutics Targeting the BRCT Domain of BARD1 Receptor – PubMed
- 2024-06-28 – Survey of Physicians and Healers Using Amygdalin to Treat Cancer Patients
- 2024-08-31 – The Effect of Amygdalin on Glioblastoma – Focus
- 2024-08 – Evaluating the therapeutic potential of amygdalin -Cytotoxic and antimicrobial properties
- 2025-01-28 – Anticancer Attributes and Multifaceted Pharmacological Implications of Laetrile and Amygdalin – PubMed
- 2025-01 – Amygdalin in antineoplastic medicine and the relevance of nanotechnology
- 2025-03-17 – The protective and chemotherapeutical role of amygdalin in induced mammary cancer in experimental mice and upregulation of related genes
- 2025-05 – Investigation of the ameliorative effects of amygdalin against arsenic trioxide-induced cardiac toxicity in rat
